Pharma
See all articles with this subject.
-
NewsTrusts could be told to stockpile equipment ahead of Brexit
NHS providers could be asked to stockpile certain types of products under government plans to mitigate the UK leaving the EU without an agreed deal.
-
News
NHS England taken to court over 'largest ever medicines procurement'
A global pharmaceutical company has taken the NHS to court over a procurement process aimed to help England become the first country to eliminate hepatitis C.
-
HSJ Partners
How can trusts reduce medication duplication and error: watch the video
Aaron Jackson, solution director for medicines at Orion Health, discusses the common causes of medication duplication and errors and what measures trusts can take to address them
-
News
Brexit: Ministers launch 'tens of millions' bid to stockpile medicine
Ministers have launched a tender worth “tens of millions” of pounds to provide extra storage capacity in the event of the UK crashing out of the EU without a deal.
-
News
NHSI to require business cases for subsidiary companies
NHS providers must submit a business case to show setting up a wholly owned subsidiary company yields value beyond VAT savings, under new proposals from NHS Improvement.
-
News
Exclusive: Trusts alerted as firm stockpiles clinical waste and body parts
Hundreds of tonnes of human body parts and dangerous waste from NHS patients has been stockpiled by a leading disposal company, sparking a major national incident.
-
News
Exclusive: No-deal Brexit 'will force up price of generic drugs'
The price of generic drugs could be forced up in the case of a no-deal Brexit, HSJ understands from senior industry sources.
-
News
NHS wins landmark legal battle against drug companies
The NHS has today won a landmark legal battle against two international pharmaceutical giants which could save the health service hundreds of millions of pounds a year.
-
News
712 unnecessary deaths – and how to avoid them: HSJ and BD roundtable
An HSJ roundtable, sponsored by BD, looked at how to reduce medication errors, improving outcomes for patients and reducing waste from unused or unnecessary medicines.
-
News
Pharma says government must act quickly to safeguard generic drugs supply
Pharmaceutical industry leaders have warned the government needs to be “fleet of foot” to avoid a significant cost if a no-deal Brexit disrupts approval of generic and biosimilar medicines.
